## Core Concept
The localization of neuroendocrine tumors (NETs) is crucial for their management. NETs are neoplasms that arise from cells of the endocrine (or neuroendocrine) system. They can originate in various parts of the body, including the pancreas, lungs, thyroid (medullary thyroid carcinoma), and gastrointestinal tract. Given their neuroendocrine origin, certain imaging modalities are more suited for their detection and localization.

## Why the Correct Answer is Right
**Somatostatin receptor scintigraphy (SRS)**, often performed using **Indium-111 pentetreotide**, is highly effective for localizing neuroendocrine tumors because many NETs express somatostatin receptors. This imaging technique takes advantage of the presence of these receptors to bind and visualize the tumors. It is particularly useful for tumors that are not easily localized by conventional imaging methods like CT or MRI, especially when the tumor is suspected but not evident on other scans.

## Why Each Wrong Option is Incorrect
- **Option A: Ultrasound**. While ultrasound can be useful for detecting pancreatic NETs and some other abdominal tumors, it is not the best modality for comprehensive localization of NETs throughout the body due to limitations in visualizing deeper structures and operator dependency.
- **Option B: CT (Computed Tomography)**. CT scans are commonly used for detecting and staging NETs but are not as sensitive as SRS for detecting smaller lesions or those with lower grades. CT is often used in conjunction with other modalities.
- **Option C: MRI (Magnetic Resonance Imaging)**. MRI provides excellent soft-tissue resolution and can be used for detecting NETs, especially in the liver and pancreas. However, like CT, it may not be as sensitive as SRS for detecting smaller or less typical lesions.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **somatostatin receptor scintigraphy (SRS)** is particularly valuable for its ability to detect neuroendocrine tumors based on their expression of somatostatin receptors. This is a high-yield fact for radiology and nuclear medicine, especially in the context of NETs. Another important aspect is that **Ga-68 DOTATATE PET/CT**, a more modern technique, has emerged as a highly sensitive and specific imaging modality for NETs, sometimes considered superior to traditional SRS due to its higher resolution and sensitivity.

**Correct Answer: D. Somatostatin receptor scintigraphy.**